Who are the Corona virus vaccine discoverers founders of Biontech - "Pfizer"
Hours after the American company "Pfizer" announced that it had developed, in cooperation with Germany, a vaccine against the Corona virus that was 90 percent effective. The spotlight is on the identity behind this innovation.
German company "Biontech"
According to European and Japanese media, behind the development of this vaccine stands the German company "Biontech", owned by a German doctor and his wife of Turkish descent. They are Ugur Sahin and Uzlam Toriji, aged 55 and 53, respectively.
Shaheen and Ozlam are the founders of Biontech.
Shaheen and Ozlam are the founders of Biontech in 2008 with $ 55 million financial support from the Bill Gates Foundation. After years of experience they gained with their first company, Ganymede Pharmaceuticals, which saw the light in 2001. It was sold to a Japanese company for $ 1.5 billion in 2016.
For years, the husband and his wife had been discussing how to boost human immunity against cancer when the new Corona epidemic appeared at the end of last year. In January 2020, they decided to focus their attention on this deadly virus, as part of their new company, Biontech. After months of intense work, they developed the vaccine, which Pfizer announced on Monday, and is awaiting obtaining a license to produce and market it.
Shaheen came to Germany from Turkey, immigrating with his father, who worked in a car factory, when he was four years old. And in Germany, he grew up and studied, to meet later “Özlam Tureigi” at the university and get married, as they not only have emotional ties, but also a love of studies and research in biology and immunology.
“Ozlam” is the daughter of a Turkish doctor who immigrated to Germany. She also devoted her life to working in laboratories.
If the husband and his wife have worked for years in German laboratories, hospitals and universities, from Cologne to Hamburg and other scientific institutions. Today, they are among the top 100 rich in Germany after the value of their company. Chahine heads, and Ozlam holds the position of chief physician at the foundation, estimated at $ 21 billion.
